Manipal Health Enterprises IPO
Manipal Health Enterprises IPO closed on 31 Jul 2026. Allotment 3 Aug 2026, listing 5 Aug 2026. Price band ₹560–₹590, lot 25 shares, GMP +₹0 (0%). Track allotment on Allotly.
| Status | Closed |
|---|---|
| Category | Mainboard · NSE & BSE |
| Price band | ₹560–₹590 |
| Lot size | 25 shares |
| Minimum investment | ₹14,750 |
| Issue size | ₹9275.22 Cr |
| GMP | +₹0 (0%) |
| Open date | 29 Jul 2026 |
| Close date | 31 Jul 2026 |
| Allotment date | 3 Aug 2026 |
| Listing date | 5 Aug 2026 |
| Registrar | KARVY |
About Manipal Health Enterprises
Manipal Health Enterprises Limited is a healthcare service provider engaged in running and managing hospitals, clinics and diagnostic centres, primarily in India. It operates a network of multi-speciality hospitals offering clinical services across several specialities, with a focus on tertiary and quaternary care such as cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and renal sciences. The company serves patients through inpatient and outpatient services, generating revenue from healthcare services paid by patients directly, insurance and third-party administrators, government schemes and corporate arrangements. Its network includes multiple hospitals supported by a large pool of doctors, and it caters to a significant volume of patients across its facilities. The company operates as a single business segment focused on medical and healthcare services…
Strengths
- A large network of multi-speciality hospitals supported by a wide base of doctors.
- Focus on high-end specialities like cardiac, oncology and neurosciences, driving revenue.
- Strong presence across key regions with ongoing expansion plans.
- Significant share of revenue from insurance and institutional payors.
- Established track record of growth in patient volumes and operations.
Risks
- High dependence on insurance and third-party administrators for revenue.
- Delays in payments from government schemes can impact cash flows.
- Expansion into new regions may face operational and market challenges.
- Failure to attract sufficient patients can lead to underutilised capacity.
- High outstanding receivables may affect working capital and liquidity.